The company also reported a 90 percent increase in gross profit, from $45.2 million to $83.5 million, as well as 15 percent decrease in expenses.
More Articles on Orthopedic Devices:
Osseon Therapeutics Names Ron Clough COO
Tibion Introduces Wireless Bionic Leg
Court Tosses Shareholders’ Lawsuit Against Synthes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.